Arch Point Investors Landos Biopharma, Inc. Transaction History

Arch Point Investors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.6 - $1.5 $892 - $2,232	-1,488 Reduced 1.16%	127,262 $93,000
Q3 2021 Nov 12, 2021	BUY	$9.77 - $15.77 $58,317 - $94,131	5,969 Added 4.86%	128,750 $1.88 Million
Q2 2021 Aug 13, 2021	BUY	$9.26 - $12.53 $234,315 - $317,059	25,304 Added 25.96%	122,781 $1.42 Million
Q1 2021 May 13, 2021	BUY	$9.47 - $16.26 $923,107 - $1.58 Million	97,477 New	97,477 $939,000

Ticker LABP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,254,900
Description
Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of u...

Get notified when there are updates to the investment portfolio of Arch Point Investors, based on Form 13F filings with the SEC.

Stay updated on Arch Point Investors with notifications on news.